Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-12

Clinical Trial Update: Attenuation of Cardiac Effects of Arteriovenous Fistula Creation With Losartan [NA]

View source ↗

Summary

Clinical trial update evaluating losartan to attenuate cardiac effects after arteriovenous fistula creation in patients with renal failure and left ventricular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan (losartan)

Snippet

Sponsor: Melbourne Health | Conditions: Renal Failure, Left Ventricular Hypertrophy | NA | Status: COMPLETED